Description

Simple

A medication used for asthma.

Clinical

A beta-2 adrenergic agonist and bronchodilator used for the symptomatic treatment of asthma.

Overview

Fenoterol is an adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.

Pharmacology

Indication

Fenoterol is used for the treatment of asthma.

Pharmacodynamic

Fenoterol is a beta agonist designed to open up the airways to the lungs by decreasing bronchconstriction.

Mechanism of action

Beta(2)-receptor stimulation in the lung causes relaxation of bronchial smooth muscle, bronchodilation, and increased bronchial airflow.

Absorption

Information currently not available.

Protein binding

Information currently not available.

Volume of distribution

Information currently not available.

Clearance

Information currently not available.

Half life

Information currently not available.

Route of elimination

Information currently not available.

Toxicity

Symptoms of overdose include angina (chest pain), dizziness, dry mouth, fatigue, flu-like symptoms, headache, heart irregularities, high or low blood pressure, high blood sugar, insomnia, muscle cramps, nausea, nervousness, rapid heartbeat, seizures, and tremor.

Adverse Effects

Contraindications

  • Regions: Canada
  • Patient Conditions:
      • Name: Tachyarrhythmias
      • Drugbank Id: DBCOND0038183
  • Regions: Canada
  • Patient Conditions:
      • Name: Hypertrophic Obstructive Cardiomyopathy
      • Drugbank Id: DBCOND0068622

Food Interactions

  • Take with or without food. The absorption is unaffected by food.

Interactions

Type in a drug name to check for interaction with Fenoterol
Type a drug name in the box above to get started
  • Paracetamol(acetaminophen)
  • Paxil(paroxetine)
  • Pamelor(nortriptyline)
  • Panadol(acetaminophen)
  • Patanol(olopatadine ophthalmic)
  • Pataday(olopatadine ophthalmic)
  • Parnate(tranylcypromine)
  • Pazeo(olopatadine ophthalmic)
1-benzylimidazole
The risk or severity of hypertension can be increased when Fenoterol is combined with 1-benzylimidazole.
1,10-Phenanthroline
The therapeutic efficacy of Fenoterol can be decreased when used in combination with 1,10-Phenanthroline.
2,5-Dimethoxy-4-ethylamphetamine
The risk or severity of adverse effects can be increased when Fenoterol is combined with 2,5-Dimethoxy-4-ethylamphetamine.
2,5-Dimethoxy-4-ethylthioamphetamine
The risk or severity of adverse effects can be increased when Fenoterol is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.
3-isobutyl-1-methyl-7H-xanthine
The risk or severity of adverse effects can be increased when Fenoterol is combined with 3-isobutyl-1-methyl-7H-xanthine.
3,5-diiodothyropropionic acid
The risk or severity of adverse effects can be increased when Fenoterol is combined with 3,5-diiodothyropropionic acid.
3,5-Diiodotyrosine
The risk or severity of adverse effects can be increased when Fenoterol is combined with 3,5-Diiodotyrosine.
4-Bromo-2,5-dimethoxyamphetamine
The risk or severity of adverse effects can be increased when Fenoterol is combined with 4-Bromo-2,5-dimethoxyamphetamine.
4-Methoxyamphetamine
The risk or severity of hypertension can be increased when Fenoterol is combined with 4-Methoxyamphetamine.
5-methoxy-N,N-dimethyltryptamine
The risk or severity of hypertension can be increased when Fenoterol is combined with 5-methoxy-N,N-dimethyltryptamine.
6-O-benzylguanine
The risk or severity of adverse effects can be increased when Fenoterol is combined with 6-O-benzylguanine.
7-Deazaguanine
The risk or severity of adverse effects can be increased when Fenoterol is combined with 7-Deazaguanine.
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
The risk or severity of adverse effects can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Fenoterol.
7,9-Dimethylguanine
The risk or severity of adverse effects can be increased when Fenoterol is combined with 7,9-Dimethylguanine.
8-azaguanine
The risk or severity of adverse effects can be increased when Fenoterol is combined with 8-azaguanine.
8-chlorotheophylline
The risk or severity of adverse effects can be increased when Fenoterol is combined with 8-chlorotheophylline.
9-Deazaguanine
The risk or severity of adverse effects can be increased when Fenoterol is combined with 9-Deazaguanine.
9-Methylguanine
The risk or severity of adverse effects can be increased when Fenoterol is combined with 9-Methylguanine.
Abaloparatide
The risk or severity of adverse effects can be increased when Fenoterol is combined with Abaloparatide.
Abediterol
The risk or severity of adverse effects can be increased when Fenoterol is combined with Abediterol.